Genital Warts Treatment, Timor-Leste | HIV STD TESTING SINGAPORE™
Genital Warts Treatment, Timor-Leste | HIV STD TESTING SINGAPORE™ @beautytimorleste_com: Genital warts (condyloma, condylomata acuminata, venereal wart, anal wart, anogenital wart, "cauliflower" sex disease) symptoms in men/women, screening/diagnosis, testing/check, treatment clinic, Timor-Leste - Private and confidential service. Definitions, references, and latest news.
Keywords: Genital Warts Treatment Timor-Leste, Timor-Leste Genital Warts Treatment, Genital Warts Treatment.
| Advertisement: Come to sunny Singapore to have your testing and treatment. Singapore Ministry of Health registered general practice (GP) clinic: |
| SHIM CLINIC|
168 Bedok South Avenue 3 #01-473
Tel: (+65) 6446 7446
Fax: (+65) 6449 7446
24hr Answering Tel: (+65) 6333 5550
Web: Genital Warts Treatment, Timor-Leste
| Opening Hours |
Monday to Friday: 9 am to 3 pm, 7 pm to 11 pm
Saturday & Sunday: 7 pm to 11 pm
Public Holidays: Closed
Last registration: one hour before closing time.
Walk-in clinic. Appointments not required.
Bring NRIC, Work Pass or Passport for registration.
Sexual risk (of HIV/STD/pregnancy), and what you can do before and after exposure.
Sensitive multiplexed DNA detection using silica nanoparticles as the target capturing platform.
Sat, 26 Jul 2014 18:35:46 +0100 | Talanta
We present a simple and sensitive method for multiplexed DNA detection by simultaneously capturing two different DNA sequences with a same silica nanoparticle (NP) through a sandwich mode. This biobarcode assay method was demonstrated by using oligonucleotide sequences of 64 bases associated with human papillomavirus (HPV) 16 and 18 L1 genes as model systems. The nonfluorescent carboxyl-modified silica NPs were prepared using water-in-oil (W/O) microemulsion methods. Avidin was immobilized on the surface of the NPs by covalent binding to the carboxyl linkers. The binding capacity of the avidin-covered NPs for ligand biotin was quantified and the results show that about 8 avidin molecules are bound to one nanoparticle. The silica nano-platforms were prepared through the biotin-avidin intera...
EUROGIN 2014 roadmap: Differences in human papillomavirus infection natural history, transmission and human papillomavirus‐related cancer incidence by gender and anatomic site of infection
Sat, 26 Jul 2014 00:00:00 +0100 | International Journal of Cancer
Human papillomaviruses (HPVs) cause cancer at multiple anatomic sites in men and women, including cervical, oropharyngeal, anal, vulvar and vaginal cancers in women and oropharyngeal, anal and penile cancers in men. In this EUROGIN 2014 roadmap, differences in HPV‐related cancer and infection burden by gender and anatomic site are reviewed. The proportion of cancers attributable to HPV varies by anatomic site, with nearly 100% of cervical, 88% of anal and <50% of lower genital tract and oropharyngeal cancers attributable to HPV, depending on world region and prevalence of tobacco use. Often, mirroring cancer incidence rates, HPV prevalence and infection natural history varies by gender and anatomic site of infection. Oral HPV infection is rare and significantly differs by gender; yet,...
HPV prevalence and genotype distribution in a population-based split-sample study of well-screened women using CLART HPV2 Human Papillomavirus genotype microarray system
Sat, 26 Jul 2014 00:00:00 +0100 | BMC Infectious Diseases
HPV prevalence and type distribution in women with normal or abnormal Pap smear in Bulgaria
Fri, 25 Jul 2014 15:05:15 +0100 | Journal of Medical Virology
Human Papillomavirus Vaccination Coverage Among Adolescents, 2007–2013, and Postlicensure Vaccine Safety Monitoring, 2006–2014 — United States
Fri, 25 Jul 2014 02:36:38 +0100 | CDC Morbidity and Mortality Weekly Report
(Source: CDC Morbidity and Mortality Weekly Report)
HPV Vax Uptake Remains Slow
Fri, 25 Jul 2014 02:13:12 +0100 | MedPage Today Public Health
(MedPage Today) -- Rates of vaccination against human papillomavirus continued to lag far behind national goals, including just a small bump in the rate since 2012, the CDC reported. (Source: MedPage Today Public Health)
CDC urges more teens to get HPV vaccine
Fri, 25 Jul 2014 01:39:26 +0100 | Health News: CBSNews.com
The Centers for Disease Control and Prevention says HPV vaccination rates for adolescent boys and girls in the United States remains unacceptably low, despite a slight increase since 2012. The human papillomavirus or HPV is the most common sexually transmitted infection. CBS News' David Begnaud reports. (Source: Health News: CBSNews.com)
HPV Vaccination Increasing, But Missed Opportunities Abound (FREE)
Fri, 25 Jul 2014 00:00:00 +0100 | Physician's First Watch current issue
By Amy Orciari Herman
Comprehensive gene expression meta-analysis of head and neck squamous cell carcinoma microarray data defines a robust survival predictor
Fri, 25 Jul 2014 00:00:00 +0100 | Annals of Oncology
National, regional, state, and selected local area vaccination coverage among adolescents aged 13-17 years - United States, 2013.
Fri, 25 Jul 2014 00:00:00 +0100 | MMWR Morb Mortal Wkl...
This report summarizes the results of that analysis, which show that from 2012 to 2013, coverage increased for each of the vaccines routinely recommended for adolescents: from 84.6% to 86.0% for ≥1 Tdap dose; from 74.0% to 77.8% for ≥1 MenACWY dose; from 53.8% to 57.3% for ≥1 HPV dose among females, and from 20.8% to 34.6% for ≥1 HPV dose among males. Coverage varied by state and local jurisdictions and by U.S. Department of Health and Human Services (HHS) region. Healthy People 2020 vaccination targets for adolescents aged 13-15 years were reached in 42 states for ≥1 Tdap dose, 18 for ≥1 MenACWY dose, and 11 for ≥2 varicella doses. No state met the target for ≥3 HPV doses.¶ Use of patient reminder and recall systems, immunization information systems, coverage assessment a...